PCM
DGX icon

Pennant Capital Management’s Quest Diagnostics DGX Stock Holding History

Pennant Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-237,778
Closed -$12.7M – 47
2013
Q4 		$12.7M Sell
237,778
-187,922
-44% -$11.1M 0.22% 41
2013
Q3 		$26.3M Sell
425,700
-91,700
-18% -$5.49M 0.47% 38
2013
Q2 		$31.4M Buy
+517,400
New +$30.8M 0.58% 36

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pennant Capital Management's DGX Position: Q1 2014 in Review

Pennant Capital Management sold out of Quest Diagnostics (DGX) in Q1 2014, closing a stake of 237,778 shares — an estimated $12.7M sold.

Pennant Capital Management first reported a position in DGX in Q2 2013 and held it in 3 quarters. The position peaked at $31.4M in Q2 2013. 491 funds tracked by Wall St. Rank hold DGX as of Q1 2014.

  • Pennant Capital Management reported no remaining Quest Diagnostics position as of Q1 2014 after selling out during the quarter.
  • Pennant Capital Management sold 237,778 Quest Diagnostics shares in Q1 2014, an estimated $12.7M.
  • Pennant Capital Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 3 quarters.
  • Pennant Capital Management's Quest Diagnostics position peaked at $31.4M in Q2 2013.
  • 491 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2014.

Based on Pennant Capital Management's 13F filing for Q1 2014, filed 15 May 2014.